source
- Eli Lilly earmarks up to $3.25 billion for partnership with InnoCare PharmaEli Lilly announced an upfront payment of $100 million to Beijing‑based InnoCare Pharma to start work on drug candidates for five targets that have critical unmet medical needs. The agreement also…
- Radioligand therapy gains momentum as experts discuss expanding patient impactIn a recent episode of the Denatured podcast presented by Curium, host Jennifer Smith-Parker spoke with Mike Patterson, CEO North America, and Sabine Brookman-May, Vice President and Head of Global…